Classification criteria of Sjögren's syndrome

Journal of Autoimmunity

Volumn 48-49, Issue , 2014, Pages 42-45

  Goules, Andreas V ^a   Tzioufas, Athanasios G ^a   Moutsopoulos, Haralampos M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

AECG criteria; Classification criteria; Primary Sj gren's syndrome

Indexed keywords

AMERICAN EUROPEAN CONSENSUS GROUP; ARTICLE; CLINICAL STUDY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DRY EYE; EXOCRINE GLAND; HISTORY OF MEDICINE; HUMAN; MEDICAL SOCIETY; MUCOSAL DRYNESS; PRIORITY JOURNAL; SJOEGREN SYNDROME; SYSTEMIC DISEASE; XEROSTOMIA;

AECG CRITERIA; CLASSIFICATION CRITERIA; PRIMARY SJÖGREN'S SYNDROME;

CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; EUROPE; HUMANS; MOUTH MUCOSA; MULTICENTER STUDIES AS TOPIC; SENSITIVITY AND SPECIFICITY; SJOGREN'S SYNDROME; UNITED STATES; VALIDATION STUDIES AS TOPIC;

EID: 84895865373     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2014.01.013     Document Type: Article

References (50)

1. Moutsopoulos H.M. Sjogren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 1994, 72:162-165.
2. Skopouli F.N., Dafni U., Ioannidis J.P., Moutsopoulos H.M. Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome. Semin Arthritis Rheum 2000, 29:296-304.
3. Ioannidis J.P., Vassiliou V.A., Moutsopoulos H.M. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome. Arthritis Rheum 2002, 46:741-747.
4. Baimpa E., Dahabreh I.J., Voulgarelis M., Moutsopoulos H.M. Hematologic manifestations and predictors of lymphoma development in primary Sjogren syndrome: clinical and pathophysiologic aspects. Med (Baltimore) 2009, 88:284-293.
5. Voulgarelis M., Tzioufas A.G., Moutsopoulos H.M. Mortality in Sjogren's syndrome. Clin Exp Rheumatol 2008, 26:S66-S71.
6. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
7. Vitali C., Bombardieri S., Moutsopoulos H.M., Balestrieri G., Bencivelli W., Bernstein R.M., et al. Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993, 36:340-347.
8. Bloch K.J., Buchanan W.W., Wohl M.J., Bunim J.J. Sjoegren's syndrome. A clinical, pathological, and serological study of sixty-two cases. Med (Baltimore) 1965, 44:187-231.
9. Morgan W.S., Castleman B. Aclinicopathologic study of Mikulicz's disease. Am J Pathol 1953, 29:471-503.
10. Anderson J.R., Gray K.G., Beck J.S., Kinnear W.F. Precipitating autoantibodies in Sjogren's disease. Lancet 1961, 2:456-460.
11. Bloch K.J., Wohl M.J., Ship I.I., Oglesby B.B., Bunim J.J. Sjogren's syndrome. 1. Serologic reactions in patients with Sjogren's syndrome with and without rheumatoid arthritis. Arthritis Rheum 1960, 3:287-297.
12. Cardell B.S., Gurling K.J. Observations on the pathology of Sjogren's syndrome. JPathol Bacteriol 1954, 68:137-146.
13. Jones B.R. Lacrimal and salivary precipitating antibodies in Sjogren's syndrome. Lancet 1958, 2:773-776.
14. Chisholm D.M., Mason D.K. Labial salivary gland biopsy in Sjogren's disease. JClin Pathol 1968, 21:656-660.
15. Waterhouse J.P., Doniach I. Post-mortem prevalence of focal lymphocytic adenitis of the submandibular salivary gland. JPathol Bacteriol 1966, 91:53-64.
16. Daniels T.E., Silverman S., Michalski J.P., Greenspan J.S., Sylvester R.A., Talal N. The oral component of Sjogren's syndrome. Oral Surg Oral Med Oral Pathol 1975, 39:875-885.
17. Prause J.U., Manthorpe R., Oxholm P., Schiodt M. Definition and criteria for Sjogren's syndrome used by the contributors to the First International Seminar on Sjogren's syndrome-1986. Scand J Rheumatol Suppl 1986, 61:17-18.
18. Homma M., Tojo T., Akizuki M., Yamagata H. Criteria for Sjogren's syndrome in Japan. Scand J Rheumatol Suppl 1986, 61:26-27.
19. Manthorpe R., Oxholm P., Prause J.U., Schiodt M. The Copenhagen criteria for Sjogren's syndrome. Scand J Rheumatol Suppl 1986, 61:19-21.
20. Fox R.I., Robinson C., Curd J., Michelson P., Bone R., Howell F.V. First international symposium on Sjogren's syndrome: suggested criteria for classification. Scand J Rheumatol Suppl 1986, 61:28-30.
21. Skopouli F.N., Drosos A.A., Papaioannou T., Moutsopoulos H.M. Preliminary diagnostic criteria for Sjogren's syndrome. Scand J Rheumatol Suppl 1986, 61:22-25.
22. Workshop on diagnostic criteria for Sjogren's syndrome. Pisa, September 30-October 1, 1988. Clin Exp Rheumatol 1989, 7:111-219.
23. Vitali C., Bombardieri S., Moutsopoulos H.M., Coll J., Gerli R., Hatron P.Y., et al. Assessment of the European classification criteria for Sjogren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren's Syndrome. Ann Rheum Dis 1996, 55:116-121.
24. Baldini C., Talarico R., Tzioufas A.G., Bombardieri S. Classification criteria for Sjogren's syndrome: a critical review. JAutoimmun 2012, 39:9-14.
25. Fox R.I., Saito I. Criteria for diagnosis of Sjogren's syndrome. Rheum Dis Clin North Am 1994, 20:391-407.
26. Binard A., Devauchelle-Pensec V., Fautrel B., Jousse S., Youinou P., Saraux A. Epidemiology of Sjogren's syndrome: where are we now?. Clin Exp Rheumatol 2007, 25:1-4.
27. Dafni U.G., Tzioufas A.G., Staikos P., Skopouli F.N., Moutsopoulos H.M. Prevalence of Sjogren's syndrome in a closed rural community. Ann Rheum Dis 1997, 56:521-525.
28. Anagnostopoulos I., Zinzaras E., Alexiou I., Papathanasiou A.A., Davas E., Koutroumpas A., et al. The prevalence of rheumatic diseases in central Greece: a population survey. BMC Musculoskelet Disord 2010, 11:98.
29. Valim V., Zandonade E., Pereira A.M., de Brito Filho O.H., Serrano E.V., Musso C., et al. Primary Sjogren's syndrome prevalence in a major metropolitan area in Brazil. Rev Bras Reumatol 2013, 53:24-34.
30. Haugen A.J., Peen E., Hulten B., Johannessen A.C., Brun J.G., Halse A.K., et al. Estimation of the prevalence of primary Sjogren's syndrome in two age-different community-based populations using two sets of classification criteria: the Hordaland Health Study. Scand J Rheumatol 2008, 37:30-34.
31. Baldini C., Talarico R., Luciano N., Tavoni A., Bombardieri S. Are the revised American-European Consensus Criteria too stringent for primary Sjogren's syndrome (pSS)? The experience on a large monocentric cohort of pSS patients. Ann Rheum Dis 2010, 69(Suppl.3):391.
32. Ramos-Casals M., Brito-Zeron P., Perez-De-Lis M., Jimenez I., Blanco M.J., Bove A., et al. Sjogren syndrome or sjogren disease? The histological and immunological bias caused by the 2002 criteria. Clin Rev Allergy Immunol 2010, 38:178-185.
33. Shiboski S.C., Shiboski C.H., Criswell L., Baer A., Challacombe S., Lanfranchi H., et al. American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2013, 64:475-487.
34. Vitali C., Bootsma H., Bowman S.J., Dorner T., Gottenberg J.E., Mariette X., et al. Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue. Ann Rheum Dis 2013, 72:476-478.
35. Bootsma H., Spijkervet F.K., Kroese F.G., Vissink A. Toward new classification criteria for Sjogren's syndrome?. Arthritis Rheum 2013, 65:21-23.
36. Cornec D., Jousse-Joulin S., Pers J.O., Marhadour T., Cochener B., Boisrame-Gastrin S., et al. Contribution of salivary gland ultrasonography to the diagnosis of Sjogren's syndrome: toward new diagnostic criteria?. Arthritis Rheum 2013, 65:216-225.
37. Ronnblom L., Eloranta M.L. The interferon signature in autoimmune diseases. Curr Opin Rheumatol 2013, 25:248-253.
38. Lisi S., Sisto M., D'Amore M., Lofrumento D.D., Ribatti D. Emerging avenues linking inflammation, angiogenesis and Sjogren's syndrome. Cytokine 2013, 61:693-703.
39. Li H., Ice J.A., Lessard C.J., Sivils K.L. Interferons in Sjogren's syndrome: genes, mechanisms, and effects. Front Immunol 2013, 4:290.
40. Stojan G., Baer A.N., Danoff S.K. Pulmonary manifestations of Sjogren's syndrome. Curr Allergy Asthma Rep 2013, 13:354-360.
41. Hernandez-Molina G., Leal-Alegre G., Michel-Peregrina M. The meaning of anti-Ro and anti-La antibodies in primary Sjogren's syndrome. Autoimmun Rev 2011, 10:123-125.
42. Yao Y., Liu Z., Jallal B., Shen N., Ronnblom L. Type I interferons in Sjogren's syndrome. Autoimmun Rev 2013, 12:558-566.
43. De Carolis S., Salvi S., Botta A., Garofalo S., Garufi C., Ferrazzani S., et al. The impact of primary Sjogren's syndrome on pregnancy outcome: our series and review of the literature. Autoimmun Rev 2014, 13:103-107.
44. Barrera M.J., Bahamondes V., Sepulveda D., Quest A.F., Castro I., Cortes J., et al. Sjogren's syndrome and the epithelial target: a comprehensive review. JAutoimmun 2013, 42:7-18.
45. Cornec D., Devauchelle-Pensec V., Tobon G.J., Pers J.O., Jousse-Joulin S., Saraux A. Bcells in Sjogren's syndrome: from pathophysiology to diagnosis and treatment. JAutoimmun 2012, 39:161-167.
46. Singh N., Cohen P.L. The T cell in Sjogren's syndrome: force majeure, not spectateur. JAutoimmun 2012, 39:229-233.
47. Bournia V.K., Vlachoyiannopoulos P.G. Subgroups of Sjogren syndrome patients according to serological profiles. JAutoimmun 2012, 39:15-26.
48. Tzioufas A.G., Vlachoyiannopoulos P.G. Sjogren's syndrome: an update on clinical, basic and diagnostic therapeutic aspects. JAutoimmun 2012, 39:1-3.
49. Tzioufas A.G., Kapsogeorgou E.K., Moutsopoulos H.M. Pathogenesis of Sjogren's syndrome: what we know and what we should learn. JAutoimmun 2012, 39:4-8.
50. Pavlakis P.P., Alexopoulos H., Kosmidis M.L., Mamali I., Moutsopoulos H.M., Tzioufas A.G., et al. Peripheral neuropathies in Sjogren's syndrome: a critical update on clinical features and pathogenetic mechanisms. JAutoimmun 2012, 39:27-33.